Cover Image

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options

Abstract Purpose Bloodstream infection (BSI) caused by Carbapenem-Resistant Enterobacteriaceae (CRE) are associated with poor outcomes in hematological patients. The aim of this study was to identify risk factors for mortality and evaluate the value of epidemiological feature of carbapenemases in gu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lining Zhang (Author), Sisi Zhen (Author), Yuyan Shen (Author), Tingting Zhang (Author), Jieru Wang (Author), Jia Li (Author), Qingsong Lin (Author), Zhijian Xiao (Author), Yizhou Zheng (Author), Erlie Jiang (Author), Mingzhe Han (Author), Jianxiang Wang (Author), Sizhou Feng (Author)
Format:	Book
Published:	BMC, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital
by: Chen Li, et al.
Published: (2019)

Carbapenem-Resistant Enterobacteriaceae-Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies
by: Kristin Ølfarnes Storhaug, et al.
Published: (2021)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
by: Yue-E Wu, et al.
Published: (2020)

Carbapenem Resistant Enterobacteriaceae in Africa
by: Bashar Haruna Gulumbe, et al.
Published: (2020)

Carbapenem-resistant Enterobacteriaceae bloodstream infections: A case-control study from a pediatric referral hospital in Argentina
by: Silvina Ruvinsky, et al.
Published: (2022)

Ruxolitinib as an Effective and Steroid-Sparing First-Line Treatment in Newly Diagnosed BOS Patients After Hematopoietic Stem Cell Transplantation
by: Xiaoyu Zhang, et al.
Published: (2022)

Carbapenem-Resistant Enterobacteriaceae in the Asia Pacific and Beyond
Published: (2019)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
by: Lilian Silva Lavagnoli, et al.
Published: (2017)

Susceptibility of Tigecycline against Carbapenem Resistant Enterobacteriaceae
by: Madeeha Fatima, et al.
Published: (2024)

Molecular characterization of Enterobacteriaceae resistant to carbapenem antimicrobials
by: Jaciane B. Marques, et al.
Published: (2015)

Incidence of carbapenem-resistant Enterobacteriaceae in the multidisciplinary pediatric hospital
by: L.G. Boronina, et al.
Published: (2020)

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
by: Yijun Ding, et al.
Published: (2019)

Molecular Characterization of Carbapenem Resistant Enterobacteriaceae in Tertiary Care Center
by: S. Alyami, et al.
Published: (2020)

Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization
by: Ihn Sook Jeong, et al.
Published: (2022)

The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: An update on the regional and local epidemiology
by: Rima I. El-Herte, et al.
Published: (2012)

Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia
by: Fawzia Alotaibi
Published: (2019)

Present and Future of Carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) Infections
by: Beatriz Suay-García, et al.
Published: (2019)

Carbapenem-Resistant Enterobacteriaceae Posing a Dilemma in Effective Healthcare Delivery
by: Angus Nnamdi Oli, et al.
Published: (2019)

Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection
by: Apichart So-ngern, et al.
Published: (2023)

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
by: Dai Y, et al.
Published: (2021)

Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae
by: Bo Gao, et al.
Published: (2019)

A systematic review and meta-analysis of carbapenem-resistant Enterobacteriaceae in West Africa
by: Namwin Siourimè Somda, et al.
Published: (2024)

Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease
by: Fangbing Tian, et al.
Published: (2023)

Triple Versus Double Therapy for the Treatment of Severe Infections Caused by Carbapenem-Resistant Enterobacteriaceae: A Systematic Review and Meta-Analysis
by: Lei Wang, et al.
Published: (2020)

Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options
by: Ghassan M. Matar
Published: (2017)

Importance of carbapenem-resistant Enterobacteriaceae screening to prevent transmission within an acute-care hospital
by: Meghan Hudziec, et al.
Published: (2023)

Quantitative Risk Assessment for the Introduction of Carbapenem-Resistant Enterobacteriaceae (CPE) into Dutch Livestock Farms
by: Natcha Dankittipong, et al.
Published: (2022)

Prevalence of carbapenemase in Enterobacteriaceae with decreased susceptibility to carbapenems isolated in a tertiary referral hospital
by: Diana M. Viegas, et al.
Published: (2018)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
by: Zhenwei Yu, et al.
Published: (2022)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020)

Infection Control for a Carbapenem-Resistant Enterobacteriaceae Outbreak in an Advanced Emergency Medical Services Center
by: Yoshiro Sakai, et al.
Published: (2021)

Antibacterial and Antibiofilm Activity of Grape Seed Extract Against Carbapenem Resistant and Biofilm Producer Enterobacteriaceae
by: Farzaneh Farshkhahi, et al.
Published: (2018)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
by: M. Ávila-Núñez, et al.
Published: (2023)

Carbapenem-Resistant <i>Enterobacteriaceae</i> (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome
by: Youssef Madney, et al.
Published: (2023)

Carbapenem-resistant Enterobacteriaceae infection in children less than one year old in an Asian medical center
by: Cha-Shien Yen, et al.
Published: (2023)

Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes
by: Dwivedi Mayank, et al.
Published: (2009)

Mortality factors and antibiotic options in carbapenem‐resistant Enterobacterales bloodstream infections: Insights from a high‐prevalence setting with co‐occurring NDM‐1 and OXA‐48
by: Palat Karnmueng, et al.
Published: (2024)

Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals
by: Feng Pang, et al.
Published: (2018)

Epidemiology of Carbapenem-Resistant <i>Enterobacteriaceae</i> Bacteremia in Gyeonggi Province, Republic of Korea, between 2018 and 2021
by: Seung Hye Lee, et al.
Published: (2023)

Colonization with Carbapenem-Resistant <i>Enterobacteriaceae</i> Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients
by: Guofen Zeng, et al.
Published: (2022)